Vertical: CNMBase Year: 2025
Market Size (2025)
$29.54M
Projected (2032)
$44.00M
CAGR (2022–2032)
5.9%
Key Players
7+
Market Overview
The global chrysanthemic acid market was valued at USD 29.54 Million in 2025 and is projected to reach USD 43.996 Million by 2032, expanding at a CAGR of 5.84% during 2026–2032. The market has grown steadily from USD 24.81 Million in 2022, and the forecast adds an absolute value of USD 14.456 Million between 2025 and 2032. Chrysanthemic acid is the cyclopropane carboxylic acid that forms the acid half of the first-generation, or chrysanthemate, synthetic pyrethroids. These include allethrin and its stereo-enriched forms, tetramethrin, prallethrin, phenothrin, cyphenothrin and imiprothrin. They are the fast-knockdown actives in mosquito coils, liquid and mat vaporizers, incense sticks and household aerosols. Demand for the acid therefore follows household and public-health insecticide consumption rather than crop protection. That consumption is concentrated in warm, densely populated regions where mosquito-borne disease is endemic.
The market is small in value but technically demanding. Production relies on cyclopropanation chemistry, isomer separation and handling of hazardous reagents such as ethyl diazoacetate. A limited number of integrated producers in Japan, China, India and Italy therefore supply most of the world's volume. Most of the acid is consumed captively in esterification to finished pyrethroid actives, and a smaller share is traded as the acid, its ethyl ester or its acid chloride.
Key Findings
Downstream Product: Pyrethroids (Allethrin & Tetramethrin) is the largest segment, at USD 25.109 Million and 85.0% of the market in 2025. Others is the fastest-growing segment, at a CAGR of 7.82%, and its share rises to 17.1% by 2032.
Purity: 98% & Above is both the largest segment, at USD 23.632 Million and 80.0% share in 2025, and the fastest-growing, at a CAGR of 6.23%. This reflects the shift toward stereo-enriched (1R)-trans grades.
Region: Asia Pacific leads with USD 23.041 Million and 78.0% of global value in 2025. Middle East & Africa is the fastest-growing region, at a CAGR of 7.35%, followed by Latin America at 6.87%.
Country: China is the leading country market, at USD 11.06 Million in 2025, equal to 37.4% of global value. Saudi Arabia is the fastest-growing country, at a CAGR of 7.67%, closely followed by UAE at 7.66%. India, at USD 5.069 Million and a CAGR of 7.41%, adds the second-largest absolute value of any country, USD 3.305 Million, between 2025 and 2032.
Segmentation Summary
The market is analysed by downstream product and purity, and across five regions and their countries. By downstream product, allethrin and tetramethrin remain the core of demand. Together they account for USD 25.109 Million in 2025, growing to USD 36.473 Million by 2032. The Others segment covers prallethrin, phenothrin, cyphenothrin, imiprothrin and other chrysanthemate esters and acid derivatives. It grows faster, from USD 4.431 Million to USD 7.523 Million, as formulators move to higher-potency actives for vaporizers and aerosols. By purity, the 98% & Above segment increases its share from 80.0% in 2025 to 82.1% in 2032. Below 98% grades grow at a slower 4.17%, mainly in coil-led, price-sensitive markets.
Competitive Landscape Summary
The market is moderately consolidated at the technical-grade level. Sumitomo Chemical originated most commercial chrysanthemate actives and still holds the broadest branded portfolio, including Pynamin Forte, Neo-Pynamin Forte, Sumithrin, ETOC, Pralle and Gokilaht. Jiangsu Yangnong Chemical, controlled by Syngenta Group, is China's largest integrated pyrethroid producer and continues to add capacity through its Liaoning Youchuang project. Endura in Italy combines its piperonyl butoxide synergist franchise with tetramethrin, prallethrin and 1R-trans-phenothrin. Indian and Chinese specialists such as Shogun Organics, Sumitomo Chemical India and Aestar (Zhongshan) supply regional formulators. Competition centres on isomer purity, cost of production, regulatory dossiers in the EU and United States, and long-term supply relationships with household insecticide brands.
Challenges and Opportunities
The main challenges are regulatory. Under the EU Biocidal Products Regulation, esbiothrin (2021) and d-allethrin (2023) were not approved for product-type 18. Tetramethrin carries a harmonised Carcinogenicity Category 2 classification, and approved chrysanthemates such as prallethrin and cyphenothrin are candidates for substitution. Further challenges are the safety and environmental demands of diazo chemistry, competition from non-chrysanthemate actives (transfluthrin, metofluthrin and newer fluorinated pyrethroids), and illegal mosquito incense sticks in South Asia that use unregistered actives.
The opportunities lie in high-burden, under-penetrated markets. The World Health Organization reported 282 million malaria cases in 2024, and dengue reached a record of more than 14 million reported cases the same year. Rising incomes in South and Southeast Asia, Africa and Latin America are moving households from coils to vaporizers and aerosols. Further opportunities come from stereo-enriched, lower-dose actives that ease regulatory scrutiny, and from backward integration by Indian producers seeking to cut dependence on imported intermediates.
Future Outlook
The market is expected to add USD 14.456 Million between 2025 and 2032. Asia Pacific contributes USD 11.707 Million of this increase, led by China (USD 5.011 Million) and India (USD 3.305 Million). Growth will be strongest where vector-borne disease pressure and household penetration gaps coincide: the Middle East & Africa (7.35%), Latin America (6.87%) and India. Mature markets in Europe (3.87%) and North America (4.17%) will grow more slowly under tighter biocide regulation. Across all regions, value will shift toward high-purity, stereo-enriched grades and toward the newer chrysanthemates in the Others segment.
The Chrysanthemic Acid Market market is projected to grow at a CAGR of 5.9% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Chrysanthemic acid (2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropane-1-carboxylic acid; molecular formula C10H16O2) is a monoterpenoid cyclopropane carboxylic acid. It was first identified as the acid component of pyrethrin I, the main insecticidal ester in pyrethrum flowers (Tanacetum cinerariifolium). The molecule has two stereocentres on the cyclopropane ring, which give four stereoisomers: (1R)-trans, (1R)-cis, (1S)-trans and (1S)-cis. The (1R)-trans isomer corresponds to the natural acid and gives the most active esters. Commercial products are therefore described by both chemical purity and isomer ratio, for example 'd-trans' or '(1R)-trans enriched'.
Industrially, chrysanthemic acid is made mainly by copper-catalysed cyclopropanation of 2,5-dimethyl-2,4-hexadiene with ethyl diazoacetate. This gives ethyl chrysanthemate as a cis/trans mixture, which is hydrolysed to the acid. The acid is then resolved, isomer-enriched or made by asymmetric catalysis, and converted to the acid chloride. The acid chloride is esterified with an alcohol to form the finished pyrethroid: allethrolone for allethrin, N-(hydroxymethyl)tetrahydrophthalimide for tetramethrin, prallethrolone for prallethrin, 3-phenoxybenzyl alcohol for phenothrin and α-cyano-3-phenoxybenzyl alcohol for cyphenothrin.
Included in scope: chrysanthemic acid in all isomeric forms and purity grades, including racemic cis/trans, trans-rich and (1R)-trans enriched grades, together with its directly derived reactive forms (ethyl chrysanthemate and chrysanthemoyl chloride) when sold or consumed to make chrysanthemate esters. Value is measured at the acid level, whether the acid is traded or used captively by integrated producers.
Excluded from scope: finished pyrethroid active ingredients and formulated insecticide products, valued separately; natural pyrethrum extract and pyrethrins; and the halogenated analogues used for second-generation pyrethroids. These analogues include 3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane carboxylic acid (DV acid or permethric acid), used for permethrin, cypermethrin and transfluthrin, and the dibromo and trifluoro-chloro acids used for deltamethrin and cyhalothrin.
Scope of the Study
This study provides historic (2022–2024), base-year (2025) and forecast (2026–2032) market values for the global chrysanthemic acid market. All values are in USD Million. Growth rates are compound annual growth rates for 2026–2032. The market is segmented as follows:
Research Objectives
To estimate and forecast the global chrysanthemic acid market in value terms (USD Million) for 2022–2032.
To analyse the market by downstream product (Pyrethroids (Allethrin & Tetramethrin) and Others) and to assess the substitution of allethrin and tetramethrin by newer chrysanthemate esters.
To assess demand by purity grade (98% & Above and Below 98%) and the move toward stereo-enriched (1R)-trans material.
To quantify regional and country-level demand across North America, Europe, Asia Pacific, Latin America and the Middle East & Africa.
To evaluate the effect of vector-borne disease burden, household insecticide formats and urbanisation on chrysanthemic acid consumption.
To examine regulatory developments affecting chrysanthemate pyrethroids, including the EU Biocidal Products Regulation, US EPA registration review and Indian and Chinese registration regimes.
To map the value chain from petrochemical feedstocks and diazo reagents to finished household insecticide products.
To profile the competitive positioning, strategies and recent developments of leading producers of chrysanthemic acid and chrysanthemate pyrethroids.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study followed a structured, multi-stage process combining secondary research, primary validation and quantitative modelling. The first stage defined the market boundary at the acid level and fixed the segmentation. Secondary research then built a baseline of production, trade, downstream pyrethroid consumption and pricing. Primary research with industry participants tested this baseline. Market size was estimated with both top-down and bottom-up methods and reconciled through data triangulation. The forecast applied driver-based adjustments to the base-year model. A final quality review checked internal consistency across segments, regions and countries.
Stage 1 – Market definition: product boundaries, isomeric forms, purity grades and the exclusion of halogenated pyrethroid acids.
Stage 2 – Secondary research: collection of regulatory, trade, corporate and technical information.
Stage 3 – Primary research: validation of volumes, prices, purity mix and growth expectations with supply- and demand-side participants.
Stage 4 – Market estimation: top-down and bottom-up sizing, triangulation and segment allocation.
Stage 5 – Forecasting and validation: driver-based projection, scenario checks and final consistency review.
Secondary Research
Secondary research drew on sources relevant to pesticide intermediates and household and public-health insecticides:
Regulatory and government bodies: US Environmental Protection Agency registration review dockets; European Chemicals Agency biocidal active substance records and EU implementing acts under Regulation (EU) No 528/2012; India's Central Insecticides Board & Registration Committee lists of registered products and indigenous manufacturers; China's Ministry of Agriculture and Rural Affairs and the Institute for the Control of Agrochemicals; Brazil's ANVISA; Japan's Ministry of Health, Labour and Welfare; and Health Canada.
Public health agencies: World Health Organization reports on malaria, dengue and vector control product specifications.
Industry associations: pesticide and crop protection industry associations in China and India, and pest management and biocide industry bodies in Europe and North America.
Company filings: annual reports, investor presentations, stock exchange disclosures and product literature of chrysanthemic acid and pyrethroid producers, and earnings commentary of household insecticide marketers.
Trade and customs data: import and export statistics for cyclopropane carboxylic acids, their esters and pyrethroid actives under the relevant Harmonized System headings.
Technical and trade literature: peer-reviewed chemistry journals, patents on chrysanthemic acid synthesis and resolution, and specialised agrochemical trade journals.
Paid databases: chemical pricing services, company financial databases and trade-flow databases.
Primary Research
Primary research validated the secondary findings and gathered information not available in published sources, such as isomer-grade pricing, captive versus merchant consumption, and how formulators choose actives. Interviews were conducted by telephone, video call and email with participants across the value chain.
Supply side: production, technical and commercial managers at chrysanthemic acid and pyrethroid active ingredient manufacturers; suppliers of key intermediates such as 2,5-dimethyl-2,4-hexadiene and ethyl diazoacetate; and chemical traders and distributors.
Demand side: procurement and R&D managers at household insecticide formulators and brand owners (coils, vaporizers, aerosols); public health and pest control product formulators; and contract manufacturers.
Independent experts: regulatory consultants on biocide and pesticide registration, and academic specialists in pyrethroid chemistry and vector control.
The objectives were to confirm market size and segment splits, understand price trends by purity grade, assess the effect of regulatory changes on active ingredient choice, and gauge growth expectations by region.
Market Size Estimation
Bottom-up approach: Demand was built up from consumption of each downstream chrysanthemate active in each country. Volumes of allethrin, tetramethrin, prallethrin, phenothrin, cyphenothrin, imiprothrin and other esters were converted to acid equivalents using stoichiometric factors and process yields. These were valued at grade-specific acid prices, and the country results were summed into regional and global totals.
Top-down approach: Global production capacity and operating rates of the main producers were used to estimate acid output. This was cross-checked against the size of the household and public-health insecticide market and the share of chrysanthemate actives within it. The global value was then allocated to regions, countries and segments using consumption patterns, trade flows and formulation mix.
Data triangulation: The bottom-up and top-down estimates were reconciled with supply-side capacity data, demand-side consumption data and primary interview inputs. Where they differed, the assumptions were re-examined until the estimates converged within an acceptable range.
Forecasting Methodology
The forecast started from the 2025 base-year model and projected each segment and country using driver-based growth rates. Factors considered include:
Vector-borne disease incidence and climate-driven expansion of mosquito habitats
Population growth, urbanisation and household penetration of insecticide formats
Substitution between chrysanthemate actives and between chrysanthemates and other pyrethroid classes
Regulatory decisions affecting approval, classification and labelling of chrysanthemate actives
Capacity additions, raw material costs and pricing trends for high- and standard-purity grades
Macroeconomic indicators such as GDP and disposable income growth
Growth rates were checked against historic trends for 2022–2024 and expert views, and the results were reviewed for consistency across segments and regions.
Base Year, Forecast Period and Currency
Base year: 2025
Historic years: 2022, 2023 and 2024
Forecast period: 2026–2032
Currency: USD Million, at nominal values; local-currency data were converted at average annual exchange rates for the respective year
Assumptions and Limitations
Market values are at the acid level and include captive consumption by integrated producers, valued at estimated merchant-equivalent prices.
Exchange rates are assumed to remain broadly stable over the forecast period.
No major new regulatory ban on allethrin or tetramethrin is assumed in the main Asian markets during the forecast period, beyond decisions already taken.
Disclosure of chrysanthemic acid production and trade is limited. Many producers are private or report pyrethroid sales without separating the acid, so some estimates rely on primary research and analyst judgement.
Trade statistics often group chrysanthemic acid with other cyclopropane carboxylic acids, which limits precision at country level.
The forecast reflects conditions known at the time of the study. Unexpected disease outbreaks, supply disruptions or regulatory changes could shift actual results.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global chrysanthemic acid market is moderately consolidated at the technical-grade level. Making the acid and its stereo-enriched forms requires hazardous cyclopropanation chemistry, isomer separation and registration support for downstream actives, so only a small number of integrated producers operate at scale. Most of these companies consume their acid captively and compete in the market for finished chrysanthemate pyrethroids, such as allethrins, tetramethrin, prallethrin, phenothrin, cyphenothrin and imiprothrin. Traded acid volumes are limited. Competition depends on isomer purity and consistency, cost position, ownership of registration dossiers in regulated markets, breadth of the chrysanthemate portfolio and long-term supply relationships with household insecticide brand owners. Japanese and European producers compete on quality, innovation and regulatory support, Chinese producers on scale and cost, and Indian producers increasingly on backward integration and proximity to the fast-growing South Asian market.
Key Player Positioning
Market Leaders
Sumitomo Chemical Co., Ltd. (Japan) is the originator of most commercial chrysanthemate pyrethroids and the most established player in the market. Its household and public-health actives include Pynamin Forte (d-allethrin), Neo-Pynamin Forte (d-tetramethrin), Sumithrin (d-phenothrin), ETOC (prallethrin), Pralle (imiprothrin) and Gokilaht (cyphenothrin). It also holds patents on making (+)-trans-chrysanthemic acid. The group reported sales revenue of JPY 2,328,515 million for FY2025, the year ended March 2026. Its strategy is to defend its originator portfolio through EU and US regulatory dossiers, including its prallethrin dossier under the EU Biocidal Products Regulation, and to sell through local subsidiaries. In April 2026 it combined its US biorational and environmental-health businesses, including MGK, into Sumitomo Biorational Company.
Jiangsu Yangnong Chemical Co., Ltd. (China) is China's largest integrated pyrethroid producer, with more than 20 hygiene pyrethroid varieties and integration from intermediates to finished actives. Listed in Shanghai and controlled by Syngenta Group, it reported revenue of RMB 11,870.43 million for FY2025. It continues to add capacity through Jiangsu Youjia and the Liaoning Youchuang base in Huludao, and it develops proprietary actives such as vinylfluthrin. Its strategy combines cost leadership from integration with access to Syngenta Group's global network.
Challengers
Endura S.p.A. (Italy) is a privately held Bologna-based producer, founded in 1980, and the leading global supplier of the synergist piperonyl butoxide. At its Ravenna plant it makes chrysanthemate actives including tetramethrin, prallethrin and 1R-trans-phenothrin. Its revenue was approximately EUR 62.3 million in FY2024. Endura's strategy pairs its synergist leadership with selected chrysanthemates supported by EU approvals and WHO specifications, and it sells in around 65 countries.
Sumitomo Chemical India Ltd. (India) is the listed Indian subsidiary of Sumitomo Chemical. It is named by India's regulator as an indigenous manufacturer of allethrin technical and markets the group's household insecticide actives to Indian formulators. It reported revenue from operations of about INR 31.9 billion for FY2025–26. Its strategy is to use its parent's portfolio and local manufacturing to serve India's fast-growing household insecticide market.
Aestar (Zhongshan) Co., Ltd. (China) is a Guangdong-based chemical manufacturer, operating since 2009, with a broad chrysanthemate portfolio covering d-trans allethrin, S-bioallethrin, esbiothrin, tetramethrin, prallethrin, phenothrin, cyphenothrin and imiprothrin, alongside piperonyl butoxide and other pyrethroids. Its revenue is not publicly disclosed. The company focuses on supplying technical actives and finished insecticide products to export markets.
Niche Players
Shogun Organics Ltd. (India), a subsidiary of Safex Chemicals, has made d-trans allethrin at its plant near Pune since 2002. It operates an integrated process through chrysanthemic acid and its acid chloride to d-trans allethrin and prallethrin. Its standalone revenue is not publicly disclosed. Its parent, Safex Chemicals, reported revenue of INR 1,584.78 crore for FY2025, the year ended March 2025. Shogun's strategy combines backward integration, its own molecules and a partnership with Godrej Consumer Products in India.
Dainihon Jochugiku Co., Ltd. (KINCHO) (Japan) is the Osaka-based company that pioneered the mosquito coil. It is a privately held, downstream integrated player whose coils, vaporizers and aerosols are major consumers of chrysanthemate actives in Japan and export markets. Its revenue is not publicly disclosed. Its strategy is brand-led, built on long experience in household insecticide formulation.
Threat of New Entrants – Low
Hazardous diazo chemistry and isomer resolution require specialised know-how, process safety systems and significant capital.
Registration dossiers for chrysanthemate actives in the EU, United States and other regulated markets are costly and slow to obtain.
Incumbents benefit from integration, scale and long-standing customer relationships.
Bargaining Power of Suppliers – Medium
Key intermediates such as 2,5-dimethyl-2,4-hexadiene and ethyl diazoacetate come from a limited number of sources, many of them in China.
Integrated producers make many intermediates in-house, which reduces supplier leverage.
Environmental inspections and plant incidents in China can tighten supply and temporarily strengthen supplier power.
Bargaining Power of Buyers – Medium
Large household insecticide brands buy significant volumes and can switch between actives or suppliers.
High-purity, registered material and qualified supply chains limit how easily buyers can switch.
Smaller formulators in fragmented markets have little leverage and often buy through traders.
Threat of Substitutes – Medium to High
Transfluthrin, metofluthrin and other fluorinated pyrethroids compete directly in vaporizers and emanators.
Natural pyrethrum extract and non-pyrethroid repellents serve niche and premium segments.
Chrysanthemates retain cost and knockdown advantages in coils, incense sticks and aerosols.
Competitive Rivalry – Medium
A small number of integrated producers dominate the technical-grade market, so rivalry is moderated by specialisation.
Chinese producers compete on cost in standard grades, while Japanese and European producers compete on purity, registrations and brands.
Rivalry is rising in India and Southeast Asia as local producers add capacity.
Threat of new entrants: Low; Hazardous chemistry, capital intensity, registration barriers.
Bargaining power of suppliers: Medium; Concentrated intermediate supply, offset by integration.
Bargaining power of buyers: Medium; Large brand owners, limited by qualification and registration.
Threat of substitutes: Medium to High; Transfluthrin and fluorinated benzyl esters in vaporizers.
Competitive rivalry: Medium; Concentrated, specialised producer base; rising Asian capacity.
Market estimates by geography (2032)
InsightAsia Pacific leads with $34.75M by 2032, while Middle East & Africa is projected to grow fastest at a 7.5% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $1.56M | $1.93M | $2.36M | 4.3% | 5% |
| Europe | $2.09M | $2.56M | $3.09M | 4.0% | 7% |
| Asia Pacific | $19.25M | $25.95M | $34.75M | 6.1% | 79% |
| Latin America | $1.44M | $2.03M | $2.82M | 6.9% | 6% |
| Middle East & Africa | $0.47M | $0.68M | $0.97M | 7.5% | 2% |
| Total | $24.81M | $33.14M | $44.00M | 5.9% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$44.00M
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Pyrethroids (Allethrin & Tetramethrin) | $36.47M | 5.5% | 83% |
| Others | $7.52M | 8.0% | 17% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Chrysanthemic Acid Market covering market dynamics, competitive landscape, and strategic outlook.
The Chrysanthemic Acid Market market is projected to reach $44.00M by 2032, growing at 5.9% CAGR. The Pyrethroids (Allethrin & Tetramethrin) segment holds the largest share.
Demand for chrysanthemic acid is driven mainly by household and public-health insecticide consumption, which depends on mosquito-borne disease burden, climate, urbanisation and consumer income. Regulation increasingly decides which chrysanthemate actives can be sold, especially in Europe. Supply depends on a small number of integrated producers and on hazardous intermediates. The factor analysis below sets out the macro and micro factors shaping the market. Each factor is scored from 1 to 10 for its expected intensity in three forecast windows. The impact scores are analyst assessments based on secondary research and interviews, not measured values.
Persistent and Rising Burden of Mosquito-Borne Disease
Mosquito-borne disease is the main structural driver of demand for chrysanthemate pyrethroids and therefore for chrysanthemic acid. The WHO World Malaria Report 2025 estimated 282 million malaria cases and 610,000 deaths in 2024, about 9 million more cases than in 2023. Dengue has spread even faster. 2024 was a record year, with more than 14 million cases reported to WHO, including over 10 million in Brazil alone. Chikungunya and Zika add to the burden in the same Aedes-infested areas. Households in these regions rely on low-cost, fast-acting space treatments, such as mosquito coils, vaporizer mats and liquids, incense sticks and aerosols, for nightly protection. Allethrin, prallethrin and tetramethrin are the standard actives in these formats because of their rapid knockdown and suitable volatility. Outbreak years produce sharp, visible spikes in insecticide demand, as in Brazil during the 2024 dengue season. Underlying incidence also raises baseline consumption across South Asia, Southeast Asia, Africa and Latin America, supporting multi-year growth in acid demand.
Urbanisation, Population Growth and Rising Household Incomes
The largest consumer markets for household insecticides, including India, China, Indonesia, Brazil and the countries of sub-Saharan Africa, combine population growth with rapid urbanisation. Dense cities with poor drainage and stored water provide ideal breeding sites for Aedes mosquitoes, and urban households are more likely to buy branded insecticide products than rural ones. As incomes rise, families move from occasional coil use to year-round use of plug-in vaporizers and aerosols. These formats use more active ingredient per household and favour higher-value actives. Leading marketers report this trend. Godrej Consumer Products, for example, has described electric vaporizers growing in double digits and incense sticks growing rapidly in India, alongside overall volume growth in household insecticides. Each step up in format and penetration adds demand for chrysanthemate actives and the acid they are made from.
Shift Toward Stereo-Enriched, High-Purity Actives
Formulators and regulators increasingly prefer stereo-enriched chrysanthemates, such as d-allethrin, d-trans allethrin, d-tetramethrin, 1R-trans-phenothrin and prallethrin with a high (1R)-trans content. These products give the same efficacy at lower doses, which reduces the active load per product and improves the human-health and environmental profile. Regulators now write isomer content into approvals: the EU approval of prallethrin under Regulation (EU) 2024/2576 sets a minimum purity of 92% with more than 80% of the 1R-trans,S isomer. This shift raises demand for high-purity chrysanthemic acid made by efficient resolution or asymmetric synthesis, and it supports higher unit prices. It is the main reason the 98% & Above segment grows faster than the market as a whole.
Public Health Vector Control Programmes
National vector control programmes and municipal mosquito abatement districts buy space-spray and residual products for outbreak response, alongside consumer purchases. In the United States, prallethrin combined with d-phenothrin is used in wide-area mosquito adulticides. The EPA's 2020 interim registration review decision for prallethrin noted the high public health benefit of this use. WHO specifications for vector control products, such as the 2025 specification for 1R-trans-phenothrin technical material, give public procurers a quality benchmark. They also open tenders in Africa, Asia and Latin America to qualified chrysanthemate suppliers. Government spending on dengue and malaria control is concentrated in the same regions where household demand is growing, which reinforces the market.
Under-Penetrated Markets in Africa, South Asia and Latin America
Household insecticide penetration remains low in much of sub-Saharan Africa, South Asia and parts of Latin America, despite the highest disease burdens. As distribution improves and low-unit-price packs spread, these markets offer the strongest growth. The Middle East & Africa (7.35%) and Latin America (6.87%) are the fastest-growing regions in this study. Producers that build regional distribution, local registrations and partnerships with formulators can capture this growth early.
Backward Integration and Supply Diversification
Buyers want to reduce dependence on a few Chinese and Japanese sources, which creates room for new or expanded acid capacity elsewhere, particularly in India. Indian producers such as Shogun Organics have already integrated through the chrysanthemic acid route to d-trans allethrin and prallethrin. Government incentives for domestic chemical manufacturing support further investment, and producers that integrate from the diene and diazo stages to the finished ester gain both cost and supply-security advantages.
Process Innovation and Next-Generation Chrysanthemates
Continuous-flow and microreactor processes for diazo chemistry promise safer, more consistent production of ethyl chrysanthemate. Improved asymmetric catalysts can raise (1R)-trans yields without wasteful resolution. Producers are also developing new chrysanthemate-type actives. Jiangsu Yangnong's vinylfluthrin, which received an ISO common name in October 2025, is built on a modified chrysanthemic acid scaffold. These innovations can lower costs and create proprietary, higher-margin acid derivatives.
Regulatory Pressure on Legacy Chrysanthemate Actives
Regulatory scrutiny of first-generation chrysanthemates is rising. Under the EU Biocidal Products Regulation, esbiothrin was not approved for product-type 18 by Implementing Decision (EU) 2021/98. d-Allethrin was not approved by Implementing Decision (EU) 2023/470, because of concerns including genotoxic photometabolites and aquatic and soil risk. Tetramethrin received a harmonised Carcinogenicity Category 2 classification under the CLP Regulation, and approved chrysanthemates such as prallethrin and cyphenothrin are designated candidates for substitution. These decisions shrink the addressable market in Europe and encourage regulators elsewhere to take similar positions. They also raise the cost of maintaining registrations, which smaller producers may be unable to bear.
Hazardous Process Chemistry and Concentrated Supply
The main industrial route depends on ethyl diazoacetate, which is unstable and has been linked to explosions. Batch reactors therefore require slow, controlled dosing and strict process safety. Combined with optical resolution steps and solvent-intensive work-up, this limits the number of capable producers and makes supply vulnerable to plant incidents or environmental inspections. Chinese chemical parks have faced repeated inspection-driven shutdowns since 2015, and the 2019 Xiangshui explosion led to closure of an entire chemical park. Events like these can tighten intermediate supply and raise prices, which discourages formulators from relying heavily on single sources.
Substitution by Other Pyrethroid Classes
Formulators increasingly use pyrethroids not made from chrysanthemic acid. Transfluthrin, built on the dichlorovinyl acid, and the fluorinated benzyl esters such as metofluthrin, meperfluthrin and renofluthrin are examples. These actives offer high vapour activity at room temperature, which suits passive emanators and modern vaporizers. Their spread, especially in India and China, caps the share of household insecticide demand that chrysanthemates can serve.
Premiumisation of Household Insecticide Formats
Brand owners are investing in plug-in liquid vaporizers, smart and low-smoke coils, fast-acting aerosols and flavoured or fragranced products. These formats need consistent, high-purity actives with tight isomer specifications, which shifts value toward premium acid grades and producers that can certify quality.
Regulatory Divergence Between Regions
Regulation is diverging. The EU is narrowing the list of approved chrysanthemates, while the United States is completing registration review with mitigation measures rather than bans, and India and China continue to register these actives widely. Producers must manage different dossiers, labels and specifications for each region, and portfolios increasingly differ by market.
Illegal and Unregistered Products
Unregistered mosquito incense sticks and coils containing unapproved actives have taken share in South Asia. Indian authorities have responded with enforcement action. In early 2026, Maharashtra banned an incense-stick brand found to contain an active not approved by the Central Insecticides Board & Registration Committee. Such products distort pricing and can divert demand away from registered chrysanthemate actives. Stronger enforcement would benefit compliant producers.
Insecticide Resistance Management
Widespread use of pyrethroids has led to resistance in Aedes and Anopheles populations in many regions. Resistance reduces the field performance of all pyrethroids, including chrysanthemates, and encourages synergist use (such as piperonyl butoxide), rotation with other classes and new actives. This challenge affects long-term demand but also creates opportunities for synergised and higher-potency formulations.
The chrysanthemic acid value chain runs from petrochemical feedstocks to household insecticide products. Most value is added at the synthesis and isomer-enrichment stages, and at the brand-owner level.
Raw Materials and Inputs
The key inputs are 2,5-dimethyl-2,4-hexadiene, made from isobutylene- or isobutyraldehyde-based C4 chemistry, and ethyl diazoacetate, made from glycine ethyl ester and a nitrite source. Copper catalysts or chiral catalysts are used for cyclopropanation. Further inputs are resolving agents, solvents, caustic soda for hydrolysis and thionyl chloride or phosgene equivalents for conversion to the acid chloride. Feedstock prices follow petrochemical cycles, while diazo reagent availability is limited by safety constraints.
Manufacturing
Manufacturers carry out cyclopropanation to ethyl chrysanthemate, hydrolysis to the acid, cis/trans separation and optical resolution or asymmetric synthesis, and conversion to chrysanthemoyl chloride. Integrated producers such as Sumitomo Chemical, Jiangsu Yangnong and Shogun Organics continue directly to esterification with the relevant alcohol (allethrolone, prallethrolone, N-hydroxymethyl tetrahydrophthalimide and others). They sell technical-grade pyrethroids rather than the acid itself. Quality control focuses on chemical purity, isomer ratio and residual impurities.
Distribution and Channels
Most chrysanthemic acid is consumed captively. Merchant volumes move through direct supply contracts between producers and pyrethroid manufacturers, and through specialist chemical traders and distributors in China, India and Europe. Finished technical pyrethroids reach formulators through direct sales, regional subsidiaries (such as Sumitomo Chemical India) and agents. Registration ownership often decides who can supply a given market.
End Users
End users are household insecticide formulators and brand owners making coils, mats, liquid vaporizers, incense sticks and aerosols, along with professional pest control and public-health formulators of space sprays and residual products. Final consumers are households, municipalities, vector control programmes and pest management companies.
North America
In the United States, chrysanthemate pyrethroids are registered under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) and are subject to periodic registration review by the US Environmental Protection Agency (EPA). In 2020 the EPA issued interim registration review decisions for tetramethrin, prallethrin, d-phenothrin, imiprothrin and cyphenothrin. These added mitigation measures such as label statements, limits on outdoor perimeter sprays and buffer zones near water. The EPA announced a final registration review decision for the d-allethrin case in August 2025. In Canada, these products are regulated under the Pest Control Products Act. Health Canada's re-evaluation of tetramethrin (RVD2018-01) continued registration with mitigation measures. Mexico regulates household insecticides through COFEPRIS.
Europe
In the European Union, insecticides for household and public-health use (product-type 18) are governed by the Biocidal Products Regulation (EU) No 528/2012. Esbiothrin (Implementing Decision (EU) 2021/98) and d-allethrin (Implementing Decision (EU) 2023/470) were not approved. Imiprothrin (Implementing Regulation (EU) 2017/2326) and cyphenothrin (Implementing Regulation (EU) 2018/1292) are approved, the latter as a candidate for substitution. Prallethrin was approved by Implementing Regulation (EU) 2024/2576 with effect from 1 March 2026, also as a candidate for substitution. The approval of 1R-trans-phenothrin was extended to 29 February 2028 by Implementing Decision (EU) 2025/950. Tetramethrin carries a harmonised Carcinogenicity Category 2 classification under the CLP Regulation (EC) No 1272/2008, introduced by Regulation (EU) 2018/1480. REACH (Regulation (EC) No 1907/2006) applies to chrysanthemic acid as an intermediate, with reduced information requirements for strictly controlled isolated intermediates.
Asia Pacific
In India, household and public-health insecticides are regulated under the Insecticides Act, 1968 and the Insecticides Rules, 1971. Products must be registered with the Central Insecticides Board & Registration Committee (CIB&RC), and manufacturing licences are issued by the states. A revised draft Pesticide Management Bill was released for consultation in January 2026. In China, Regulations on Pesticide Administration (State Council Order No. 677, effective 1 June 2017) define products used against mosquitoes, flies and cockroaches as pesticides. These hygiene pesticides require registration with the Ministry of Agriculture and Rural Affairs, with technical evaluation by the Institute for the Control of Agrochemicals (ICAMA). In Japan, insecticides against mosquitoes, flies and similar pests are regulated as quasi-drugs, or in some cases pharmaceuticals, under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices (PMD Act).
Latin America and Middle East & Africa
In Brazil, household insecticides are regulated by ANVISA as 'saneantes desinfestantes' under Resolution RDC No. 682 of 2022, which requires product registration. Argentina regulates domestic insecticides through its national health authority (ANMAT). In the Middle East & Africa, household insecticides are typically registered with national health or municipal authorities. Public-health procurement in Africa often references WHO specifications and prequalification for vector control products.
Jan 2022: Endura S.p.A.; Acquisition; Acquired ACTIVA Srl, expanding its product and formulation capabilities.
H1 2022: Jiangsu Yangnong Chemical; Capacity expansion; Phase 3 of the Jiangsu Youjia project reached full production, and the first stage of Phase 4 began production.
Jun 2022: Endura S.p.A.; Investment; Secured EUR 12.45 million in SACE-guaranteed financing from Intesa Sanpaolo for new production lines, capacity and R&D.
Dec 2022: Endura S.p.A.; Regulatory approval; Received an EU notice of approval for its 1R-trans-phenothrin technical material.
Aug 2024: Shogun Organics Ltd.; Product launch; Launched renofluthrin, a patented household insecticide molecule, with exclusive use in India granted to Godrej Consumer Products.
Oct 2024: Sumitomo Chemical; Endura S.p.A.; Regulatory approval; Prallethrin approved for product-type 18 under the EU Biocidal Products Regulation (Implementing Regulation (EU) 2024/2576), effective 1 March 2026, on separate dossiers from both companies.
Mar 2025: Jiangsu Yangnong Chemical; Capacity expansion; Reported completion of the first stage of Phase 1 at its Liaoning Youchuang base in Huludao six months ahead of schedule, with commissioning yielding on-specification product.
Jul 2025: Shogun Organics Ltd. (Safex Chemicals); Corporate; Parent Safex Chemicals filed draft IPO papers with SEBI, earmarking part of the proceeds to repay Shogun Organics' borrowings.
Sep 2025: Endura S.p.A.; Regulatory / quality; WHO specification 356/TC for 1R-trans-phenothrin technical material was based on Endura's product.
2025: Endura S.p.A.; Expansion / product launch; Opened a new headquarters in Bologna, marked its 45th anniversary and launched PBO Prime.
Oct 2025: Jiangsu Yangnong Chemical; New active ingredient; ISO common name vinylfluthrin approved for its new pyrethroid, built on a modified chrysanthemic acid scaffold.
Mar 2026: Jiangsu Yangnong Chemical; Capacity expansion; Reported that Liaoning Youchuang was profitable from start-up, with Phase 2 expected in 2026.
Apr 2026: Sumitomo Chemical; Restructuring; Launched Sumitomo Biorational Company, combining Valent BioSciences, MGK and Valent North America.
Aug 2026: Jiangsu Yangnong Chemical; Capacity expansion; Second stage of Phase 1 at Liaoning Youchuang entered trial production with on-specification output, and approvals for Phase 2 began.
Political
Government malaria and dengue control programmes create sustained public procurement of insecticides.
Industrial policy in India and China supports domestic production of agrochemical intermediates.
Trade tensions and export controls can disrupt cross-border supply of intermediates.
Economic
Rising disposable incomes in emerging markets drive the move to higher-value insecticide formats.
Petrochemical feedstock prices and energy costs affect production costs.
Currency movements affect the competitiveness of Chinese, Indian, Japanese and European exporters.
Social
Growing awareness of dengue and malaria prevention increases household insecticide use.
Urban consumers prefer smoke-free and fragrance-free formats such as vaporizers.
Concern about indoor air quality and chemical exposure shapes product choice.
Technological
Asymmetric catalysis and improved resolution raise (1R)-trans yields and purity.
Continuous-flow processing can make diazo chemistry safer.
New chrysanthemate-type molecules extend the life of the chemistry.
Environmental
Aquatic toxicity of pyrethroids drives buffer zones and disposal labelling.
Climate change expands the range and season of disease-carrying mosquitoes.
Chemical park inspections and emission limits in China affect production.
Legal
The EU Biocidal Products Regulation restricts which chrysanthemates can be sold in Europe.
US EPA registration review imposes mitigation measures and data requirements.
Registration and licensing in India, China and Brazil determine market access.
Profiles of 103 companies operating in the Chrysanthemic Acid Market market, including revenue, employee count, and market positioning where available.
Showing 103 of 103 companies
DuPont de Nemours today is a focused, roughly USD 7 bn-revenue multi-industry company. It is no longer the diversified chemical conglomerate of its heritage. After a decade of portfolio surgery, the company consists of two segments: **Healthcare & Water Technologies (about 47% of FY2025 sales):** Tyvek® medical packaging and protective garments, specialty medical device components (Spectrum, Donatelle), and the FilmTec™ / Amberlite™ water purification franchise. **Diversified Industrials (about 53%):** Building envelope products (Tyvek® house wrap, Styrofoam™, Corian®) and engineered industrial technologies (Molykote®, Vespel®, Betaseal™/Betaforce™ adhesives, Cyrel® printing plates). The company earns a premium-specialty margin profile: operating EBITDA margin was 23.8% in FY2025, with guidance of about 24.5% for FY2026. Management targets 3–4% organic growth, 150–200 bps of margin expansion and 8–10% adjusted EPS CAGR through 2028, supported by a lightly levered BBB+/Baa1 balance sheet. The principal overhang is legacy PFAS liability, shared with Chemours, Corteva and Qnity under contractual arrangements. The principal opportunity is a cleaner, higher-growth healthcare/water mix and capital redeployment. --- **Company's own description (FY2025 10-K, Item 1).** DuPont describes itself as a leading provider of advanced solutions that improve everyday life across healthcare, water, construction and industrial markets. It emphasizes helping customers advance their technology pipelines, from clean water to medical packaging that enhances safety and performance. It names its competitive strengths as: - proprietary product and process technologies; - robust application-development pipelines; - well-known brands; - customer intimacy; - global manufacturing and local service capability. **Independent characterization.** DuPont is now best understood as a specialty engineered-materials and components company with four businesses of roughly comparable scale: **Business model and revenue model.** - Revenue is overwhelmingly product sales: materials, components, membranes, resins, garments and plates. Some engineered systems and modules are sold in Water. - There is no material subscription or licensing revenue. Trade secrets may be licensed occasionally (10-K, Intellectual Property). - The contract manufacturing and design services of Spectrum and Donatelle (medical devices) add a design-in / build-to-print services element, but are recognized as product revenue. - Seasonality: North American Building Technologies demand peaks in Q2–Q3. **Value-chain position.** DuPont sits mid-stream as a Tier-1/Tier-2 supplier. It converts purchased raw materials (polyolefins, specialty monomers, resins, silicones, polymers) into engineered materials, membranes and components. These are specified into customers' finished products: medical devices, sterile packaging, water plants, building envelopes, aircraft, vehicles and print packaging. **Customer types.** - Medical device OEMs and sterile packaging converters - Biopharma manufacturers - Industrial end users and EPC/OEM water-system integrators - Municipalities and desalination operators (via integrators) - Builders, contractors and distributors (e.g., Corian® distribution through Hallmark and Parksite) - Automotive and EV OEMs and Tier-1s - Aerospace OEMs - Printing and packaging converters Most products are sold through DuPont's own sales organization, with distributors used for some lines (10-K, Distribution). **End markets.** Healthcare (medical devices, packaging, biopharma, PPE), water (industrial, municipal/desalination, life sciences, microelectronics UPW), construction (residential, non-residential, repair/remodel) and industrial (aerospace, automotive/EV, printing and packaging, general industrial).
Nippon Soda is a mid-cap, diversified Japanese chemical group founded in 1920 as a chlor-alkali producer and progressively re-shaped into a portfolio anchored by two high-value franchises: research-based crop protection (Agri Business, 35% of FY3/26 sales) and specialty "Chemical Materials" (25%), complemented by lower-margin but stable trading/logistics, plant engineering and environmental-recycling businesses. Its crown jewels are niche, high-barrier products in which it holds globally relevant positions — the pharmaceutical excipient NISSO HPC (hydroxypropyl cellulose), liquid polybutadiene NISSO-PB for AI-server copper-clad laminates, KrF photoresist polymer VP-POLYMER, and proprietary agrochemicals such as Mospilan (acetamiprid) and Topsin-M. With FY3/26 net sales of JPY 152.1 billion, record net profit of JPY 18.3 billion, an equity ratio of ~66.6%, and a 50%+ total shareholder return policy, the company is a conservatively financed, R&D-led specialty player now pivoting toward healthcare (including animal health) and advanced ICT materials under its Stage III plan to FY3/30. --- ### Company's own description According to its Stage III medium-term plan (May 2026), Nippon Soda describes its mission as creating new value through the power of chemistry, and frames the group as supporting everyday life through chemical products and services across four "material" fields: Agriculture (securing food and sustainable agriculture), Healthcare (healthy life for all people), Environment (toward a resource-recycling society) and ICT (chemical functions for IT devices). The Yuho describes the parent's business as manufacturing, processing and marketing of industrial chemicals, synthetic resins and plastics, dyes, pharmaceuticals, agrochemicals, veterinary pharmaceuticals and other chemical products. ### Business model and revenue model Nippon Soda's revenue is overwhelmingly product-based (manufactured chemical sales), with secondary service revenues from logistics (warehousing, transport, customs brokerage), engineering/EPC contracts and waste treatment. There is no material subscription revenue. Licensing/active-ingredient supply is embedded in Agri Business: the company supplies proprietary active ingredients (AIs) to global majors and sells formulated products through its own overseas network and partners. The revenue mix by nature (approximation from FY3/26 segment data; company does not disclose a product/service split): *Note: the above split is an analytical characterization; the company does not report revenue by nature.* ### Value-chain position **Agri Business:** fully integrated R&D-type agrochemical originator — chemical synthesis, biological/safety research, formulation research, field evaluation, AI manufacturing (including via Nisso Namhae Agro in Korea) and formulation, registration and global marketing (Stage III plan). The company emphasizes that R&D-type agrochemical originators are largely limited to five overseas majors plus Japanese firms, and that Japanese originators punch above their weight in new AI discovery. **Chemical Materials:** upstream chlor-alkali (caustic soda, chlorine, hydrochloric acid) feeding downstream fine/specialty chemistry (living anionic polymerization for NISSO-PB and VP-POLYMER; cellulose derivatization for HPC; penem API synthesis). **Trading & Logistics:** captive and third-party distribution (Nisso Shoji) and specialized hazardous/pharma logistics (Sanwa Soko, Sanso Unyu). **Engineering:** fine-chemical-type EPC (Nisso Engineering) and civil works (Nisso Kensetsu). **Eco Solutions:** waste treatment, zinc recovery from electric-arc-furnace dust, sulfuric acid recycling (Nisso Metallochemical). ### Customer types and end-markets Customers include global agrochemical majors and distributors, farmers' cooperatives (via channels), generic and innovator pharmaceutical companies and supplement makers (HPC, SSF, faropenem API), copper-clad-laminate (CCL) and semiconductor-materials producers (NISSO-PB, 1,2-SBS, VP-POLYMER), thermal-paper manufacturers (color developers), battery-materials producers, industrial users of commodity chemicals, steelmakers (EAF dust treatment), and public/private construction clients (Engineering). End-markets: crop protection (fruit & vegetables first, expanding to grains), pharmaceuticals/nutraceuticals, semiconductors/electronics (AI servers, HBM, automotive chips), infrastructure, and environmental services. ### Independent characterization Nippon Soda is best understood as two engines and three stabilizers. The engines — Agri Business and specialty Chemical Materials — generated roughly 75% of FY3/26 segment operating profit (JPY 11.2 billion of JPY 14.97 billion before adjustments) on 60% of sales. Agri is cyclical and FX-sensitive (65.7% overseas sales ratio in FY3/26), while Chemical Materials has been structurally re-rated from a ~5–6% margin business to ~15–17% after exiting commodity lines (metallic sodium via Alkaline S.A.S., NISSO HI-CHLON, phenol-based color developers, sodium cyanide). The stabilizers (Trading & Logistics, Engineering, Eco Solutions) are low-growth and modest-margin but add scale and cash. A further, often-overlooked profit pillar is equity-method income (JPY 6.06 billion in FY3/26, chiefly Iharabras in Brazil), which made ordinary profit (JPY 22.99 billion) much larger than operating profit and is highly FX-sensitive (BRL/USD).
RPM International is a holding company for more than a dozen semi-autonomous specialty-chemicals franchises. These businesses make coatings, sealants, roofing, concrete admixtures, flooring, fireproofing and building-envelope systems, mostly for maintenance, repair and restoration rather than new construction. Its brand portfolio is unusually deep for a USD 7.9 billion company: Rust-Oleum, DAP, Zinsser, Varathane and The Pink Stuff on the consumer side; Tremco, Euclid, Dryvit, Nudura, Kalzip, Stonhard, Carboline and Fibergrate on the professional side. Each brand holds a leading position in a niche that larger diversified coatings groups do not dominate. Since 2018 RPM has run successive operational-improvement programs (MAP to Growth, MAP 2025, and now "MAP 3.0"). These have lifted gross margin from about 36% (FY2022) to about 41% (FY2026) and moved the group from a loose federation toward a centrally coordinated operating company. RPM is a disciplined, dividend-growing compounder with 52 consecutive annual dividend increases. Its growth vectors are engineered building systems, emerging markets (the "Platform" model) and bolt-on M&A. --- ### Company's own description (FY2026 Form 10-K, Item 1) RPM describes itself as follows: its subsidiaries manufacture, market and sell specialty chemical product lines, including high-quality specialty paints, infrastructure rehab and repair products, protective coatings, roofing systems, sealants and adhesives. These products focus on the maintenance and improvement needs of the construction, industrial, specialty and consumer markets. Footprint as of 31 May 2026: - Products marketed in about 167 countries and territories. - Manufacturing in about 120 locations across 22 countries. - About 31% of sales generated internationally: foreign operations 29.8% of net sales, plus direct U.S. exports of 0.9%. The press-release boilerplate calls RPM "a world leader in specialty coatings, sealants, building materials and related services." ### Business model RPM's model has four defining features. - **Decentralised entrepreneurial structure, becoming more integrated.** The founder's philosophy, still quoted in the 2026 proxy, is: "Hire the best people you can find. Create an atmosphere that will keep them. Then let them do their jobs." Operating companies historically kept their own brands, sales forces and ERP systems. The MAP programs are deliberately centralising procurement, manufacturing, accounting and IT. The stated goal is to consolidate more than 75 ERP systems to one platform per segment (Q4 FY2026 8-K). **Repair and maintenance bias:** Much of the portfolio serves existing assets: roof restoration, re-cover, concrete repair, corrosion control, rust prevention and DIY touch-up. That demand is less cyclical than new-build construction. The FY2026 10-K notes that re-roofing has historically accounted for over three-quarters of U.S. roofing demand. **Systems and turnkey selling:** In CPG and PCG, RPM increasingly sells integrated systems (the "Power of One" building envelope) and supply-and-apply turnkey services. Examples include Stonhard flooring installation and Weatherproofing Technologies roofing services. This captures more of each construction project's spend. **Bolt-on M&A plus organic growth:** RPM completed six acquisitions in each of FY2025 and FY2026 (FY2026 10-K Note F). ### Revenue model mix RPM does not disclose a product versus service versus licensing split. From filings, the mix is: ### Value-chain position RPM is a formulator and brand owner, positioned downstream of commodity chemical producers. It buys petroleum-derived resins, solvents, pigments, minerals, metals and packaging (FY2026 10-K, Raw Materials). It is selectively backward-integrated: RPM cites expanding in-house raw material production, and Arnette Polymers makes amine curing agents and epoxy intermediates. Channels downstream include: - Mass merchants and home centres, where the single largest Consumer customer was 20% of Consumer sales in FY2026. - Hardware and paint stores. - Distributors. - Contractors and specifiers. - Direct sales to industrial plant owners, public institutions and infrastructure agencies. ### Independent characterisation RPM is best understood as a portfolio of niche category leaders with a structural margin-improvement story layered on top. The professional segments (CPG and PCG) are about 66% of sales and supply the growth. In FY2026 they posted record results driven by high-performance buildings, data centres, infrastructure, fireproofing and concrete admixtures. In Q1 FY2027, emerging-market regions grew more than 20%. The Consumer segment is about 34% of sales. It is a cash-generative but volume-challenged DIY business. Organic Consumer sales fell 0.8% in Q4 FY2026 and 4.7% in Q2 FY2026. They recovered to +5.2% in Q1 FY2027 on shelf-space wins and pricing. The equity debate therefore centres on three questions: 1. Can MAP savings and pricing protect margins against renewed raw-material inflation linked to the Middle East conflict? 2. Is the Q1 FY2027 CPG slowdown temporary? 3. Will the 9 November 2026 investor day credibly frame the next margin plan?
3 interactive charts drawn from the Chrysanthemic Acid Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Chrysanthemic Acid Market By Purity
Global Chrysanthemic Acid Market By Downstream Product
Global Chrysanthemic Acid Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)
